Form 4: Marimed Executive Reports Stock Transaction
Insider Transaction (Form 4)
Ryan Crandall, Chief Commercial Officer of Marimed Inc., reported multiple transactions in common stock on July 15, 2026.
Summary
- Option exercise/conversion: acquired 32,813 Common stock on July 15, 2026; holds 1,135,616 after (Direct).
- Tax/exercise-price withholding: disposed of 11,370 Common stock at $0.07 ($753) on July 15, 2026; holds 1,124,246 after (Direct).
- Option exercise/conversion: disposed of 32,813 Restricted Stock Units (RSU) on July 15, 2026; holds 98,437 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Ryan Crandall — Officer (Chief Commercial Officer)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-07-15 | Option exercise/conversion | Common stock | 32,813 | — | — | 1,135,616 |
| 2026-07-15 | Tax/exercise-price withholding | Common stock | 11,370 | $0 | $753 | 1,124,246 |
| 2026-07-15 | Option exercise/conversion | Restricted Stock Units (RSU) | 32,813 | — | — | 98,437 |
Key Dates
| Date | Description |
|---|---|
| 2026-07-15 | Option exercise/conversion (32,813 shares) |
| 2026-07-15 | Tax/exercise-price withholding (11,370 shares) |
| 2026-07-15 | Option exercise/conversion (32,813 shares) |
Keywords
insider transaction, Form 4, MRMD, MARIMED INC., neutral, Ryan Crandall
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.